Karyopharm Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Karyopharm Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Karyopharm Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.7M | 3.2M | 0.83 |
| 2024-06-30 | $2.8M | 3.2M | 0.87 |
| 2024-03-31 | $4.8M | 3.2M | 1.51 |
| 2023-12-31 | $2.7M | 3.1M | 0.87 |
| 2023-09-30 | $4.2M | 3.1M | 1.34 |
| 2023-06-30 | $5.7M | 3.2M | 1.79 |
| 2023-03-31 | $14M | 3.7M | 3.89 |
| 2022-12-31 | $13M | 3.9M | 3.40 |
| 2022-06-30 | $2.7M | 603k | 4.51 |
| 2022-03-31 | $8.0M | 1.1M | 7.37 |
| 2021-12-31 | $9.5M | 1.5M | 6.43 |
| 2021-09-30 | $7.9M | 1.4M | 5.82 |
| 2021-06-30 | $13M | 1.2M | 10.31 |
| 2021-03-31 | $10M | 975k | 10.53 |
| 2020-12-31 | $6.5M | 423k | 15.48 |
| 2020-09-30 | $17M | 1.2M | 14.60 |
| 2020-06-30 | $5.8M | 308k | 18.94 |
| 2020-03-31 | $33M | 1.7M | 19.21 |
| 2019-12-31 | $30M | 1.6M | 19.17 |
| 2019-09-30 | $16M | 1.6M | 9.62 |
| 2019-06-30 | $5.5M | 924k | 5.99 |
| 2019-03-31 | $11M | 1.9M | 5.84 |
| 2018-12-31 | $3.0M | 321k | 9.37 |
| 2018-09-30 | $4.9M | 287k | 17.05 |
| 2018-06-30 | $3.2M | 190k | 16.99 |
| 2018-03-31 | $1.7M | 125k | 13.43 |
| 2017-12-31 | $521k | 54k | 9.59 |
| 2017-09-30 | $395k | 36k | 10.98 |
| 2017-06-30 | $553k | 61k | 9.05 |
| 2017-03-31 | $1.3M | 99k | 12.84 |
| 2016-12-31 | $432k | 46k | 9.39 |
| 2016-09-30 | $286k | 29k | 9.74 |
| 2015-12-31 | $303k | 23k | 13.26 |
| 2015-09-30 | $6.1M | 579k | 10.53 |
| 2015-03-31 | $779k | 26k | 30.59 |
| 2014-12-31 | $11k | 281 | 39.15 |
| 2014-06-30 | $3.7M | 79k | 46.55 |